SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                -----------------

                                    Form 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


        Date of Report (Date of earliest event reported): March 22, 2001


                           BIOPOOL INTERNATIONAL, INC.
               (Exact Name of Registrant as Specified in Charter)


         Delaware                    0-17714                    58-1729436
(State or Other Jurisdiction       (Commission              (IRS Employer
   of Incorporation)               File Number)              Identification No.)


                              370 Interlocken Blvd.
                           Broomfield, Colorado 80021
                    (Address of Principal Executive Offices)

                                 (800) 944-4479
                         (Registrant's Telephone Number)





ITEM 5.  OTHER EVENTS

     Reference  is made to the press  release  of Biopool  International,  Inc.,
d/b/a XTRANA Inc. (the "Registrant"),  issued on March 22, 2001, announcing 2000
year-end and fourth quarter results. A copy of the press release, which contains
information  meeting the  requirements  of this Item 5, is attached to this Form
8-K as Exhibit 99.1 and is incorporated herein by this reference.

     Further  reference is made to the press release of the Registrant issued on
April  9,  2001,  announcing  that  the  Registrant  entered  into a  settlement
agreement with Agen Biomedical Ltd. with regard to a patent infringement lawsuit
filed by Agen Biomedical against the Registrant on March 10, 2000. A copy of the
press release,  which contains information meeting the requirements of this Item
5, is attached to this Form 8-K as Exhibit  99.2 and is  incorporated  herein by
this reference.



ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

(a)  Financial Statements. None.

(b)  Pro Forma Financial Information. None.

(c)  Exhibits.

     Exhibit 99.1      Press Release of the  Registrant  dated
                       March 22, 2001,  announcing  2000 year-end
                       and fourth quarter results.

     Exhibit 99.2      Press Release of the Registrant dated
                       April 9, 2001, announcing that the
                       Registrant has entered into a settlement
                       agreement with Agen Biomedical Ltd.


                                       2





                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


April 9, 2001                               BIOPOOL INTERNATIONAL, INC.



                                           By:  /S/ TIMOTHY DAHLTORP
                                                -------------------------------
                                                Timothy Dahltorp
                                                Chief Financial Officer


                                       3






                                  EXHIBIT INDEX

EXHIBIT                                                              PAGE NUMBER

99.1     Press Release of the Registrant dated March 22, 2001,            5
         announcing 2000 year-end and fourth quarter results.

99.2     Press Release of the Registrant dated April 9, 2001,             8
         announcing that the Registrant has entered into a
         settlement agreement with Agen Biomedical Ltd.


                                       4